CymitQuimica logo

SSR128129E

CAS:

Ref. TR-S684470

5mg
193.00€
25mg
407.00€
100mg
1,275.00€
SSR128129E
TRC

    Product Information

    Name:SSR128129E
    Controlled Product
    Synonyms:
    • 2-Amino-5-[(1-methoxy-2-methyl-3-indolizinyl)carbonyl]-benzoic Acid Sodium Salt
    • 2-Amino-5-[(1-methoxy-2-methyl-3-indolizinyl)carbonyl]-benzoic Acid Monosodium Salt
    • SSR 128129E
    • Sodium 2-Amino-5-[(1-methoxy-2-methylindolizin-3-yl)carbonyl]benzoate
    Brand:TRC
    Description:Applications SSR128129E (SSR) is an potent FGFR inhibitor, which inhibits fibroblast growth factor receptor (FGFR). Oral delivery of SSR128129E inhibits arthritis and tumors that are relatively refractory to anti-vascular endothelial growth factor receptor-2 antibodies.
    References Bono, F., et al.: Cancer Cell., 23, 477 (2013); Dol-Gleizes, F., et al.: PLoS One, 8, e80027 (2013)
    Notice:Our products are intended for lab use only. For any other use, please contact us.

    Chemical properties

    Molecular weight:346.31
    Formula:C18H15N2NaO4
    Color/Form:Yellowish Solid
    InChI:InChI=1S/C18H16N2O4.Na/c1-10-15(20-8-4-3-5-14(20)17(10)24-2)16(21)11-6-7-13(19)12(9-11)18(22)23;/h3-9H,19H2,1-2H3,(H,22,23);/q;+1/p-1
    InChI key:InChIKey=JFBMSTWZURKQOC-UHFFFAOYSA-M
    SMILES:COc1c(C)c(C(=O)c2ccc(N)c(C(=O)O[Na])c2)n2ccccc12

    Technical inquiry about: SSR128129E

    Please use instead the cart to request a quotation or an order

    If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
    ◻️
    CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
    * Mandatory fields.